Julia L. Greenstein, Ph.D.

Vice President, Discovery Research

Julia L. Greenstein, Ph.D., serves Breakthrough T1D as the vice president of discovery research, which includes early-stage programs across the Breakthrough T1D portfolio.

Dr. Greenstein has more than 20 years of experience in the corporate biotechnology arena, holding leadership positions that have helped accelerate discoveries to market. Before joining Breakthrough T1D as a consultant in 2005, Dr. Greenstein was the chief executive officer and president of Immerge BioTherapeutics, a Novartis and BioTransplant joint venture focused on the development of pig xenotransplantation for clinical practice. Prior to this position, she held the roles of chief scientific officer and senior vice president of research at BioTransplant and vice president of discovery research at ImmuLogic Pharmaceutical Corp.

Dr. Greenstein received her bachelor’s degree in biochemistry from Russell Sage College and her doctorate in microbiology from University of Rochester School of Medicine and Dentistry, under the direction of Dr. Philippa Marrack. Dr. Greenstein was an assistant professor at the Dana- Farber Cancer Institute of Harvard Medical School after completing her postdoctoral work there and at the University of Rochester.